血浆置换联合连续性血液净化治疗肝衰竭患者短期疗效观察

doi:10.3969/j.issn.1672-5069.2018.03.042

Abstract

Yang Xiaoling, Zhou Qiang, Zheng Chunhua, et al. Analysis of plasma exchange and continuous blood purification in treatment of patients with hepatitis B liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 469-470.

References

[1] ABektas M,Idilman R,Soykan I,et al.Djuvant therapeutic plasma exchange in liver failure:assessments of clinical and laboratory parameters.J Clin Gastroenterol,2008,42(5):517-521.
[2] Jie J,Zhou F,Kang H,et al.Unexpected extrapyramidal symptoms and pulmonary aspergillosis in exertional heatstroke with fulminant liver failure:a case report. J Med Case Rep,2017,11(1):37.
[3] Akdogan M,Camci C,Gurakar A,et al.The effect of total plasma exchange on fulminant hepatic failure. J Clin Apher,2006,21(2):96-99.
[4] Du WB,Li LJ,Huang JR,et al.Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc,2005,37(10):4359-4364.
[5] Yu JW,Wang GQ,Zhao YH,et al.The MELD scoring system for predicting prognosis in patients with severe hepatitis after plasma exchange treatment. Hepatobiliary Pancreat Dis Int,2007,6(5):492-496.
[6] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南.实用肝脏病杂志,2013,16(3):210-216.
[7] Kim JD,Choi JY,Park CH,et al.Clinical features of patients with fulminant hepatitis A requiring emergency liver transplantation:comparison with acute liver failure due to other causes.Korean J Hepatol,2010,16(1):19-28.
[8] Kaffarnik M F,Ahmadi N,Lock J F,et al.Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity(LiMAx test). A prospective study.PLoS One,2017,12(5):e0178237.
[9] 范晶华,陈红英,王宏图,等. 血浆置换联合血浆灌流治疗肝衰竭患者临床疗效分析. 实用肝脏病杂志,2016,19(2):184-187.
[10] Li M,Wang Z,Wang Y,et al.Part of plasmapheresis with plasma filtration adsorption combined with continuous hemodiafiltration in the treatment of severe acute liver failure. Exp Ther Med,2016,12(4):2582-2584.
[11] Di C,Santoro MC,Gaspari R,et al.Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure. Transplant Proc,2005,37(6):2547-2550.
[12] Yamamoto R,Nagasawa Y,Marubashi S,et al.Early plasma exchange for progressive liver failure in recipients of adult-to-adult living-related liver transplants. Blood Purif,2009,28(1):40-46.
[13] Annicchiarico BE,Avolio AW,Siciliano M,et al.Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation.Transplant Proc,2008,40(6):1929-1931.
[14] 王朝旭,李叶宁,王文龙,等. 血浆置换联合胆红素吸附治疗慢加亚急性肝衰竭患者疗效及血清细胞因子水平变化. 实用肝脏病杂志,2017,20(4):492-493.
[15] Osada S,Saji S.The clinical significance of monitoring alkaline phosphatase level to estimate postoperative liver failure after hepatectomy. Hepatogastroenterology,2004,51(59):1434-1438.
[16] Tek I,Arslan O,Arat M,et al.Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure.Transfus Apher Sci,2004,31(2):89-93.
[17] Udayakumar N,Subramaniam K,Umashankar L,et al.Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease:a preliminary observation.J Clin Gastroenterol,2007,41(10):922-926.

Analysis of plasma exchange and continuous blood purification in treatment of patients with hepatitis B liver failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[15]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.